TOKYO, July 15, 2025 /PRNewswire/ -- Fujitsu Limited and Acer Medical Inc., a provider of AI-powered medical imaging and preventative medicine, today announced a collaborative agreement to develop "aiGait" powered by Uvance, a solution that leverages Fujitsu's advanced skeleton...
Hence then, the article about fujitsu and acer medical trial ai service that assesses future disease risk in elderly patients through gait pattern abnormality detection was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Fujitsu and Acer Medical trial AI service that assesses future disease risk in elderly patients through gait pattern abnormality detection )
Also on site :
- Globant Files Annual Report for 2025
- How America’s Action in Venezuela Guaranteed Guyana’s Oil Future
- U.S. Crude Daily Average Production Falls in December as Bakken Leads Pullback